Pharmacy Benefit Managers Are Killing Indie Pharmacies and Limiting Patient Choice
Independent Pharmacies of Maryland
It’s Not Just Big Pharma: Meet the Middlemen Blocking Access to Medication
Higher Drug Costs, Less Choice: How PBMs Affect Everyday Americans’ Healthcare
Drug middlemen say Pharma sets prices. Then why do middlemen have hundreds for the same drug?
Do pharmacy benefit managers play a role in pharmacy closures?
Pharmacy benefit managers profit at expense of patients and small pharmacies, FTC says
Maryland could cap prices for Ozempic and other diabetes drugs
Op-Ed: Health care middlemen don’t benefit NJ patients or pharmacists
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
As pharmacies shutter, some Western states, Black and Latino communities are left behind
Patients, pharmacists march against PBM business model
Congress needs to stop pharmacy benefit managers from wrongly impeding access to drugs
Navarro Announces Completion of First Pharmacy Benefit Manager Exams
UnitedHealth Group CEO takes bipartisan heat in Senate hearing over cyberattack
David Balto: End the link between PBMs and drug prices
Commentary: How lawmakers can protect copay assistance
Congressman on PBMs: ‘They've essentially become extortion artists’
Under threat from industry ‘middlemen,’ independent pharmacies gain allies in D.C., Frankfort
A Bipartisan Coalition of 39 State Attorneys General Urge Congressional Action on Pharmacy Benefit Manager Reform
House panel passes PBM bill that bans spread pricing, only allows a flat service fee